Telmisartan
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00966 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 41 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | Prinzmetal angina | KG + DL |
| 2 | brain stem infarction | KG + DL |
| 3 | ABri amyloidosis | KG + DL |
| 4 | cerebral artery occlusion | KG + DL |
| 5 | pulmonary hypertension owing to lung disease and/or hypoxia | KG + DL |
| 6 | pulmonary hypertension with unclear multifactorial mechanism | KG + DL |
| 7 | malignant renovascular hypertension | KG + DL |
| 8 | malignant hypertensive renal disease | KG + DL |
| 9 | intracerebral hemorrhage | KG + DL |
| 10 | Braddock syndrome | KG + DL |
| 11 | cerebral arterial disease | KG + DL |
| 12 | MRI defined brain infarct | KG + DL |
| 13 | autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome | KG + DL |
| 14 | brain small vessel disease 1 with or without ocular anomalies | KG + DL |
| 15 | chronic pulmonary heart disease | KG + DL |
| 16 | diabetic nephropathy | KG + DL |
| 17 | spinal cord ischemia | KG + DL |
| 18 | myocardial infarction | KG + DL |
| 19 | posteroinferior myocardial infarction | KG + DL |
| 20 | posterolateral myocardial infarction | KG + DL |
| 21 | septal myocardial infarction | KG + DL |
| 22 | cholesterol embolism | KG + DL |
| 23 | sagittal sinus thrombosis | KG + DL |
| 24 | homozygous familial hypercholesterolemia | KG + DL |
| 25 | hypoalphalipoproteinemia | KG + DL |
| 26 | chronic renal failure syndrome | KG + DL |
| 27 | cardiac tamponade | KG + DL |
| 28 | coronary thrombosis | KG + DL |
| 29 | congenital coronary artery anomaly | KG + DL |
| 30 | transient ischemic attack (disease) | KG + DL |
| 31 | thrombophilia, familial, due to decreased release of tissue plasminogen activator | KG + DL |
| 32 | angiokeratoma | KG + DL |
| 33 | coronary stenosis | KG + DL |
| 34 | atrial fibrillation (disease) | KG + DL |
| 35 | obsolete familial combined hyperlipidemia | KG + DL |
| 36 | sick sinus syndrome 2, autosomal dominant | KG + DL |
| 37 | ABeta amyloidosis | KG + DL |
| 38 | chronic kidney disease | KG + DL |
| 39 | acute coronary syndrome | KG + DL |
| 40 | sarcoglycanopathy | KG + DL |
| 41 | end stage renal failure | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.